Volume 19, Number 2—February 2013
Synopsis
Lessons and Challenges for Measles Control from Unexpected Large Outbreak, Malawi
Andrea Minetti
, Matthew Kagoli, Agnes Katsulukuta, Helena Huerga, Amber Featherstone, Hazel Chiotcha, Delphine Noel, Cameron Bopp, Laurent Sury, Renzo Fricke, Marta Iscla, Northan Hurtado, Tanya Ducomble, Sarala Nicholas, Storn Kabuluzi, Rebecca F. Grais, and Francisco J. Luquero
, Matthew Kagoli, Agnes Katsulukuta, Helena Huerga, Amber Featherstone, Hazel Chiotcha, Delphine Noel, Cameron Bopp, Laurent Sury, Renzo Fricke, Marta Iscla, Northan Hurtado, Tanya Ducomble, Sarala Nicholas, Storn Kabuluzi, Rebecca F. Grais, and Francisco J. LuqueroTable 3
Results from the vaccine effectiveness study in 8 districts, Malawi, 2010*
| Vaccination status | Total | No. cases | Attack rate, %† | Vaccine effectiveness |
|
|---|---|---|---|---|---|
| Crude, % (95% CI) | Adjusted, % (95% CI)‡ | ||||
| Unvaccinated |
793 |
91 |
13.3 |
Referent |
Referent |
| Vaccinated with MCV | |||||
| 1 dose§ | 2512 | 62 | 2.4 | 82.0 (72.9–88.1) | 83.9 (70.8–90.8) |
| 2 doses¶ | 1777 | 22 | 1.1 | 91.6 (84.7–95.4) | 90.5 (79.7–95.5) |
*Districts are Blantyre, Mzimba, Lilongwe, Thyolo, Chiradzulu, Mangochi, Balaka, and Machinga. MCV, measles-containing vaccine.
†Weighted and adjusted by the study design.
‡Adjusted by age, sex, and literacy of the caregiver.
§Routine immunization.
¶Routine immunization and 2008 supplementary immunization activities.
